Project Details
Short title | PICCle: Phase I/II clinical trial to assess the efficacy and safety of the drug AZD2281, a PARP-inhibitor, in relapsed and refractory Chronic Lymphocytic Leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patien |
---|---|
Status | Finished |
Effective start/end date | 1/09/09 → 31/12/17 |
Funding
- BLOODWISE
- THE BRITISH SOCIETY FOR HAEMATOLOGY
- ASTRA ZENECA UK LIMITED